Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies (Q38078696)
Jump to navigation
Jump to search
scientific article published on 31 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies |
scientific article published on 31 January 2013 |
Statements
1 reference
Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies (English)
1 reference
clostridium histolyticum
1 reference
Wayne J G Hellstrom
1 reference
Irwin Goldstein
1 reference
Martin Gelbard
1 reference
Chris G McMahon
1 reference
Ted Smith
1 reference
James Tursi
1 reference
Nigel Jones
1 reference
Gregory J Kaufman
1 reference
Culley C Carson
1 reference
31 January 2013
1 reference
1 reference
190
1 reference
1
1 reference
199-207
1 reference
Identifiers
1 reference
1 reference